Hybridization Approach to Identify Salicylanilides as Inhibitors of Tubulin Polymerization and Signal Transducers and Activators of Transcription 3 (STAT3)
Open Access
- 6 July 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (7) , 835
Abstract
The superimposition of the X-ray complexes of cyclohexanediones (i.e., TUB015), described by our research group, and nocodazole, within the colchicine binding site of tubulin provided an almost perfect overlap of both ligands. This structural information led us to propose hybrids of TUB015 and nocodazole using a salicylanilide core structure. Interestingly, salicylanilides, such as niclosamide, are well-established signal transducers and activators of transcription (STAT3) inhibitors with anticancer properties. Thus, different compounds with this new scaffold have been synthesized with the aim to identify compounds inhibiting tubulin polymerization and/or STAT3 signaling. As a result, we have identified new salicylanilides (6 and 16) that showed significant antiproliferative activity against a panel of cancer cells. Both compounds were able to reduce the levels of p-STAT3Tyr705 without affecting the total expression of STAT3. While compound 6 inhibited tubulin polymerization and arrested the cell cycle of DU145 cells at G2/M, similar to TUB015, compound 16 showed a more potent effect on inhibiting STAT3 phosphorylation and arrested the cell cycle at G1/G0, similar to niclosamide. In both cases, no toxicity towards PBMC cells was detected. Thus, the salicylanilides described here represent a new class of antiproliferative agents affecting tubulin polymerization and/or STAT3 phosphorylation.Keywords
Funding Information
- Consejo Superior de Investigaciones Científicas (PIE-201980E100, PID2019-105117RR-C22/AEI/10.13039/501100011033)
- Agencia Estatal de Investigación (PIE-201980E100, PID2019-105117RR-C22/AEI/10.13039/501100011033)
This publication has 30 references indexed in Scilit:
- Design, synthesis and mode of action of some benzothiazole derivatives bearing an amide moiety as antibacterial agentsRSC Advances, 2014
- Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck CancerPLOS ONE, 2013
- Discovery of novel 2-hydroxydiarylamide derivatives as TMPRSS4 inhibitorsBioorganic & Medicinal Chemistry Letters, 2013
- An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding SitePharmaceutical Research, 2012
- A Simple Copper-Catalyzed Synthesis of Tertiary Acyclic AmidesOrganic Letters, 2011
- Geranylated flavanone tomentodiplacone B inhibits proliferation of human monocytic leukaemia (THP‐1) cellsBritish Journal of Pharmacology, 2010
- Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling PathwayACS Medicinal Chemistry Letters, 2010
- Cryptotanshinone Inhibits Constitutive Signal Transducer and Activator of Transcription 3 Function through Blocking the Dimerization in DU145 Prostate Cancer CellsCancer Research, 2008
- Design, Synthesis, and Multivariate Quantitative Structure−Activity Relationship of SalicylanilidesPotent Inhibitors of Type III Secretion inYersiniaJournal of Medicinal Chemistry, 2007
- F⋅⋅⋅H-N Hydrogen Bonding Driven Foldamers: Efficient Receptors for Dialkylammonium IonsAngewandte Chemie International Edition, 2005